Navigation Links
Soligenix Reports Third Quarter 2011 Financial Results
Date:11/14/2011

PRINCETON, N.J., Nov. 14, 2011 /PRNewswire/ -- Soligenix, Inc. (OTCBB: SNGX) (Soligenix or the Company), a development stage biopharmaceutical company, announced today its financial results for the third quarter of 2011.

Soligenix's revenues for the third quarter of 2011 were approximately $5,796,000 as compared to $861,000 for the third quarter of 2010. The increase in revenues was a result of a $5 million license fee from Sigma-Tau Pharmaceuticals, Inc. (Sigma-Tau) in connection with the expansion of its existing North American commercialization rights to orBec® and oral BDP into the European Territory (the Sigma-Tau Agreement).

Soligenix's net income for the third quarter of 2011 was approximately $2,205,000, or $0.01 per share, as compared to a (loss) of ($1,734,000), or $(0.01) per share for the third quarter of 2010. Recognition of income for the current quarter is attributable to the Sigma-Tau Agreement offset by R&D costs in connection with the conduct of the confirmatory Phase 3 clinical trial of orBec® in acute gastrointestinal Graft-versus-Host disease (GI GVHD).

Research and development expenses for the third quarter of 2011 were approximately $2,342,000 as compared to $1,277,000 for the third quarter of 2010.  This increase is primarily attributable to payment of approximately $1,000,000 in the form of cash and company stock to our orBec® licensor in connection with the Sigma-Tau Agreement. General and administrative expenses for the third quarter of 2011 were approximately $595,000, compared to approximately $543,000 for the third quarter of 2010.

As of September 30, 2011, the Company's cash position was approximately $7,218,000 with working capital of approximately $6,257,000.  

Christopher J. Schaber, PhD, President and Chief Executive Officer of Soligenix stated, "The third quarter saw the unfortunate stoppage of our confirmatory Phase 3 trial of orBec® in acute GI GVHD at th
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Soligenix Announces Formation of Pediatric Crohns Disease Medical Advisory Board
2. Soligenix Announces Results of Recent Data Safety Monitoring Board Review for Phase 3 orBec® Study in Acute GI GVHD
3. Soligenix Reports Second Quarter 2011 Financial Results and Reviews Accomplishments
4. Soligenix Announces Expansion of Partnership With Sigma-Tau Pharmaceuticals for orBec® in Europe
5. Soligenix Announces Appointment of Jerome Zeldis, MD, PhD and Keith Brownlie, CPA to its Board of Directors
6. Soligenix Appoints Joseph Warusz as Vice President of Administration and Controller
7. Soligenix to Present at 13th Annual BIO CEO & Investor Conference
8. Soligenix Appoints Kevin Horgan, MD, as Chief Medical Officer
9. Soligenix Executes Exclusive License with the University of Colorado for Vaccine Thermostabilization Technology
10. Soligenix Announces Positive Preliminary Results of SGX202 in Radiation Injury
11. Soligenix Announces Preliminary Results of its Phase 2 Clinical Trial of orBec® in the Prevention of Acute GVHD
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... SAN ANTONIO , May 6, 2015   GenSpera, ... "Injectable Cancer Compositions" has entered the national phase application process ... , Eurasia, Japan , China ... the United States . When awarded, the resulting patent ... property around its entire platform technology, including its lead drug ...
(Date:5/6/2015)... , May 6, 2015 ... What does the future hold for the ... brand new report shows you potential revenues to 2025, ... Our new 189 page report provides 115 tables, charts, ... most lucrative areas in the industry and the future ...
(Date:5/6/2015)... , May 6, 2015  TriStar Wellness ... company that targets opportunities in the advanced wound ... Portland, Oregon based wholly owned independent ... awarded funding from the National Institutes of Health ... dressing that is able to be delivered by ...
Breaking Medicine Technology:GenSpera Enters National Phase with Patent Application for Injectable Prodrug Formulations 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 2Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 3Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 4Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 5Advanced Wound Care Market Forecast 2015-2025: Prospects for Leading Companies in Wound Care Biologics, Moist Wound Care and Wound Care Devices 6Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 2Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 3Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 4Collaboration Between HemCon and OHSU is Awarded Additional NIH Grant with Total Value of $1.1M for the Development of a Transurethral Hemostatic Device 5
(Date:5/6/2015)... (PRWEB) May 06, 2015 As ... the HIMSS EMR Adoption Model, the hospital looked ... patient engagement and automate processes. The leadership team ... paper-driven to electronic workflows, patient registration still required ... of consents. With HIMSS Stage 7 attestation fast ...
(Date:5/6/2015)... 2015 Qushanna Doby (20) was arrested for ... treatment center in Florida while under the influence of Flakka, ... surveillance tapes released by CBS4’s Peter D’Oench records Doby distraught ... child is around one year old. The drug treatment center ... was not named. The residents polled by CBS Miami express ...
(Date:5/6/2015)... Chesapeake Regional Medical Center is ... to acquire Intuitive Surgical, Inc.’s latest model of ... includes enhanced surgical technique capabilities, which can be ... wide spectrum of specialties. Its advancements allow patients ... recovery times. , “As the only independent, community-based ...
(Date:5/6/2015)... May 06, 2015 Baptist Medical ... the first in north Florida and southeast Georgia ... the latest innovation in total hip replacement surgery ... surgeon-controlled robotic arm that enables the accurate alignment ... Jacksonville has offered MAKOplasty® partial knee resurfacing using ...
(Date:5/6/2015)... 06, 2015 Animals make just as good ... also good for your health. An Ohio veterinarian ... increase he's seeing with health advantages of owning a pet. ... it comes to pet ownership, there are proven health benefits ... Scott Leffler of the Animal Medical Center of ...
Breaking Medicine News(10 mins):Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 2Health News:Access Electronic Patient Signatures Help Hilo Meet HIMSS Stage 7 Paperless Targets & Save $200,000 a Year on Consent Forms 3Health News:Flakka Induced Mother Abandons Baby, found by Florida Drug Treatment Center; New Video Released 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 2Health News:Chesapeake Regional Medical Center Obtains First da Vinci® XI Robotic Surgical System in Virginia 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 2Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 3Health News:Baptist Health and Jacksonville Orthopaedic Institute Offering MAKOplasty® Total Hip Replacement 4Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 2Health News:Veterinarian Supports 2015 HABRI Study Citing Increase in Health Advantages of Pet Owners 3
... members, money to UHW-W,treasury from outside fund, WASHINGTON, ... United Healthcare Workers West (UHW-W) violated federal,law and deceived ... in dues money to an outside fund under their ... SEIU in United States District,Court for the Central District ...
... Revised and expanded YOU: The Owner,s Manual released today, ... got even,better! YOU: The Owner,s Manual, Updated and Expanded ... bookstores today. The original book,published by HarperCollins in 2005, ... the best-selling books across all titles in 2005. The ...
... American Heart Association advocates call on lawmakers to ... With risk factors for,heart disease and stroke steadily ... from across the country today urged,Congress to make ... their,representatives for the American Heart Association,s (AHA) Congressional,Lobby ...
... Ones At ... on May 2, PHOENIX, April 29 Remuda Programs ... inpatient,treatment center for women and girls suffering from eating disorders, ... new book "Distorted -,How a Mother and Daughter Unraveled the ...
... April 29 Elbit Imaging Ltd.,(the "Company") (Nasdaq: ... Fidelity Trust Company Ltd., the trustee for the holders ... Company (the "Trustee" and the "Notes",respectively), that due to ... firms, Zohar, Zohar & Co., the controlling shareholder of,the ...
... normal range associated with dangers , , TUESDAY, April 29 ... normal range may increase the risk of fatal coronary ... Thyrotropin, a hormone produced by the pituitary gland, is ... gland to stimulate its growth and function. , "Emerging ...
Cached Medicine News:Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 2Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 3Health News:Top UHW-W Officers Violated Federal Law, Deceived Members in Diverting Millions in Dues Money to Outside Fund 4Health News:America's Favorite Doctors Try to Outdo Their Own Blockbuster 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 2Health News:Hundreds of Heart Disease and Stroke Survivors Urge Congress to Step Up the Fight Against the Nation's No. 1 Killer 3Health News:Authors Of New Critically Acclaimed Book 'Distorted' Share Their Journey From an Eating Disorder at a Book Signing Event in Wickenburg 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 2Health News:Elbit Imaging Ltd. Announces Termination of Service of Trustee for Holders of Series A, B and C Notes 3Health News:Pituitary Hormone May Boost Women's Heart Risk 2
... versatile power supply in its class. Capable ... 1250 milliamps or 325 watts, it easily ... power supply is capable of providing the ... small focusing gels and the current required ...
Capable of producing up to 500 volts and 500 milliamps, this power supply is ideal for PAGE, SDS-PAGE, DNA or RNA submarine gels as well as all types of small format transfer apparatus....
... as submarine electrophoresis and SDS-PAGE, to DNA ... 90 Programmable Power Supplies will support virtually ... Supplies are available in four different output ... operate in constant voltage, current or power ...
The Programmable MP-3500P-F Power Supply can be applied for any Microfluidic application....
Medicine Products: